Abstract
The present article describes comparative pharmacokinetic study of different generic oral forms of amoxicillin — soluble tablets «Flemoxin Solutab», manufactured by «Astellas Pharma Europe B.V.», Netherlands, and powder for suspension «Amosin», manufactured by «Sintez», Russia. The study group consisted of 18 healthy volunteers each of that sign written informed consent form. Discordance of main pharmacokinetic parameters and lack of bioequivalence of studied generics were revealed. It has been shown that soluble tablets «Flemoxin Solutab» have pharmacokinetic parameters that allow to achieve more stable concetrations of amoxicillin than powder for suspension «Amosin». In accordance to the results of the study it can be concluded that «Flemoxin Solutab» has significantly favorable PK/PD profile for the treatment of pneumococcal infections caused by penicillin-intermediate and resistant strains.
-
1.
Leggett J.E., Fantin B., Ebert S., Totsuka K., et al. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thighinfection models. J Infect Dis 1989;159(2):281-92.
-
2.
Drusano G.L. Antimicrobial pharmacodynamics: critical interactions of ‘bug and drug’. Nat Rev Microbiol 2004; 2(4):289-300.
-
3.
Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26(1):1-10; quiz 1-2.
-
4.
Craig W.A., Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15(3):255-9.
-
5.
Craig W.A. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 1995;22(1-2):89-96.
-
6.
Leggett J.E., Ebert S., Fantin B., Craig W.A. Comparative dose-effect relations at several dosing intervals for betalactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. Scand J Infect Dis Suppl 1990; 74:179-84.
-
7.
Агафонов А.А., Пиотровский В.К. Программа М-ind системы параметров фармакокинетики модельнонезависимым методом статистических моментов.// Хим.-фарм. журн. – 1991, № 10, С.16-9.
-
8.
Бондарева И.Б. Статистический анализ данных исследований биоэквивалентности.// Клин. фармакокинет. – 2004, №1, С.14-22.
-
9.
Методические указания МЗиСР РФ «Проведение качественных клинических исследований биоэквивалентности лекарственных препаратов». М., 2008.
-
10.
de Abreu L.R., Ortiz R.A. HPLC determination of amoxicillin comparative bioavailability in healthy volunteers after a single dose administration.// J. Pharm. Pharmaceut. Sci. – 2003, 6(2), P.223-30.
-
11.
Dousa M.; Hosmanova R. Rapid determination of amoxicillin in premixes by HPLC.// Journal of pharmaceutical and biomedical analysis – 2005, 37(2), P.373-7.
-
12.
Kennedy D.G., McCracken R.J., Cannavan A., Hewitt S. A. Use of liquid chromatography-mass spectrometry in the analysis of residues of antibiotics in meat and milk// J. Chromatography A – 1998, 812, P.77-98.